Continuous renal replacement therapy and ECMO in COVID patients, a Moroccan case report experience

Younes Oujidi 1, *, Imane Melhaoui 2, Layla Kherroubi 3, Houssam Bkiyar 1 and Brahim Housni 1

1 Anaesthesia and Resuscitation Service – Hospital University Mohammed VI of Oujda. Oujda Faculty of Medicine and Pharmacy, Mohammed Premier University, Oujda, Morocco.
2 Nephrology Department – Hospital University Mohammed VI of Oujda. Oujda Faculty of Medicine and Pharmacy, Mohammed Premier University, Oujda, Morocco.
3 Internal medicine Department – Hospital University Mohammed VI of Oujda. Oujda Faculty of Medicine and Pharmacy, Mohammed Premier University, Oujda, Morocco.
 
Case Study
World Journal of Advanced Research and Reviews, 2021, 09(02), 159-162
Article DOI: 10.30574/wjarr.2021.9.2.0059
 
Publication history: 
Received on 15 January 2021; revised on 17 February 2021; accepted on 19 February 2021
 
Abstract: 
Introduction: Extracorporeal membrane oxygenation (ECMO) is a therapy that ameliorate the oxygenation of hypoxemia refractory patient it could be associated to a kidney failure that necessity a Continuous Renal Replacement Therapy.
Case Report: We report the case of a 68-year-old patient, who presents ARDS due to covid infection, during his hospitalisation the patient presented a refractory hypoxemia with the need to set up ECMO, the case worsened with kidney failure with need for CRRT.
Conclusion: The association between ECMO and CRRT might be a safe and effective technique. A variety of ECMO and CRRT combination methods can be chosen, this remains an association that should be investigated in order to improve the prognosis of kidney failure on ECMO.
 
Keywords: 
COVID; ECMO; CRRT; SDRA
 
Full text article in PDF: 
Share this